Pasar al contenido principal

VISUALIZANDO EL ESQUELETO BODIPY COMO MATERIAL "HOT-EXCITON" PARA DESARROLLAR DISPOSITIVOS DE LUZ AVANZADOS: UNA PRUEBA DE CONCEPTO

PID2023-149991NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Water-soluble BODIPY dyes: a novel approach for their sustainable chemistry and applied photonics

  • Schad, Christopher
  • Ray, Cesar
  • Díaz-Norambuena, Carolina
  • Serrano-Buitrago, Sergio
  • Moreno, Florencio
  • Maroto, Beatriz L
  • García-Moreno, I.
  • Muñoz-Úbeda, Mónica
  • López-Montero, Iván
  • Bañuelos, Jorge
  • de la Moya, Santiago
10 pages, 4 figures, 4 tables, The BODIPY family of organic dyes has emerged as a cornerstone in photonics research development, driving innovation and advancement in various fields of high socio-economic interest. However, the majority of BODIPY dyes exhibit hydrophobic characteristics, resulting in poor solubility in water and other hydrophilic solvents. This solubility is paramount for their optimal utilization in a myriad of photonic applications, particularly in the realms of biology and medicine. Furthermore, it facilitates safer and more sustainable manipulation and chemical modification of these expansive dyes. Nevertheless, bestowing BODIPYs with water solubility while preserving their other essential properties, notably their photophysical signatures, poses a significant challenge. In this context, we present a straightforward general chemical modification aimed at converting conventional hydrophobic BODIPYs into highly hydrophilic variants, thus enabling their efficient solubilization in water and other hydrophilic solvents with minimal disruption to the dye's inherent photophysics. The efficacy of this methodology is demonstrated through the synthesis of a number of water-soluble BODIPY dyes featuring diverse substitution patterns. Furthermore, we showcase their utility in a spectrum of photonics-related applications, including in-water BODIPY chemistry and dye-laser technology, and fluorescence microscopy., S. d. l. M. acknowledges support from Spanish MICINN, (AEI/ 10.13039/501100011033; research grants PID2020-114755GBC32 and PID2024-157648-NB-C21). S. S.-B. acknowledges UCM for a pre-doctoral contract (CT58/21-CT59/21). J. B. acknowledges support from Spanish MICINN (AEI/10.13039/ 501100011033; research grants PID2020-114755GB-C33 and PID2024-157648-NB-C22) and Basque Government (research grant IT1639-22). C. D.-N. acknowledges Spanish MICINN for a pre-doctoral contract (PRE2018-086808). I. G.-M. acknowledges support from Spanish MICINN (AEI/10.13039/ 501100011033; research grant PID2023-149991NB-I00), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Combination of Q-switched 1,064 and 532 nm Nd: YAG laser in the treatment of toenail onychomycosis: a pilot study

  • Gómez-Hernández, María Clara
  • Alberdi, Enrique
9 pages, 3 figures, 2 tables, Previous studies have demonstrated that laser-based therapies can effectively improve the appearance of nails affected by onychomycosis, offering a high safety margin, making them suitable for patients in whom systemic antifungal agents are contraindicated. Building on earlier studies, a pilot clinical trial was designed to assess the effectiveness of a Q-switched Nd: YAG laser using dual wavelengths (1,064 nm and 532 nm) for the treatment of toenail onychomycosis. This study involved 15 participants with distal lateral subungual onychomycosis (DLSO) of the big toe caused by dermatophytes. Each laser session included two applications of 1,064 Nd: YAG laser at 600 mJ/pulse, 20 ns, 2 Hz, for 1 min, separated by a 1-minute pause. After a 2-minute rest, the 532 nm laser was applied in a similar manner using the same parameters. Treatments were administered weekly over eight weeks. Progress was monitored using the Onychomycosis Severity Index (OSI), based on direct clinical examination and photographs taken at baseline, during each session, and at follow-up visits. Mycological clearance was assessed via PAS-stained histopathology and fungal culture. Pain during treatment was evaluated using a visual analogue scale (VAS), and any side effects were recorded. At week 43, both mycological cure rate (MCR) and complete cure rate (CCR) were 33.3% (5 out 15 patients). The laser therapy was well-tolerated, with no reported adverse effects. Pain scores averaged 6.5 ± 0.5 during the 1,064 nm application and 7.8 ± 0.5 during the 532 nm application. Despite some discomfort, patient satisfaction remained high. The dual-wavelength Q-switched Nd: YAG laser appears to be a promising treatment option for mild onychomycosis, although its effectiveness is limited in severe onychomycosis. Further research is needed to optimize laser parameters, session frequency, and follow-up duration to maximize therapeutic outcomes., This work was supported by a grant from the Fundación Eugenio Rodríguez Pascual (Madrid, Spain) and by the Spanish National Plan for Scientific and Technical Research and Innovation (PID 2023149991NB-100), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Light-Based Therapies for Treatment of Onychomycosis

  • Gómez-Hernández, María Clara
  • Alberdi, Enrique
19 pages, 3 figures, 1 table, Onychomycosis is a chronic fungal infection of the nail, and its treatment is considered a challenge. The use of systemic antifungals is frequently associated with multiple adverse effects; moreover, topical antifungals are rarely effective when used as a monotherapy. Non-pharmacological alternative treatment modalities are needed. Progress in this direction includes experimentation with light-based therapies: administration of laser radiation through the use of long-pulsed and Q-switched Nd:YAG, CO2 , infradiode, fractional ablative lasers, and other light sources for photodynamic therapy or intense pulsed light (IPL). These therapies exert their effect through various mechanisms: selective photothermolysis, a non-selective thermal effect that decomposes the infected tissue and has a sterilizing effect, or the induction of photochemical reactions, damaging fungal structures. Well-designed clinical trials are still needed to assess efficacy and establish the best treatment guidelines. It is expected that technological innovation will enable the design of more advanced light devices, enhancing their efficacy and achieving a positive societal impact., This work was supported by a grant from Fundación Eugenio Rodríguez Pascual (Madrid, Spain) and by the Spanish National Plan for Scientific and Technical Research and Innovation (PID 2023-149991NB-100). The authors also wish to acknowledge the support for open access by the CSIC Open Access Publication Support Initiative, Peer reviewed